全文获取类型
收费全文 | 594篇 |
免费 | 58篇 |
出版年
2023年 | 4篇 |
2021年 | 6篇 |
2020年 | 4篇 |
2018年 | 7篇 |
2017年 | 7篇 |
2016年 | 11篇 |
2015年 | 10篇 |
2014年 | 24篇 |
2013年 | 21篇 |
2012年 | 33篇 |
2011年 | 29篇 |
2010年 | 20篇 |
2009年 | 14篇 |
2008年 | 22篇 |
2007年 | 24篇 |
2006年 | 21篇 |
2005年 | 20篇 |
2004年 | 18篇 |
2003年 | 25篇 |
2002年 | 28篇 |
2001年 | 24篇 |
2000年 | 15篇 |
1999年 | 18篇 |
1998年 | 4篇 |
1997年 | 9篇 |
1995年 | 7篇 |
1994年 | 7篇 |
1993年 | 9篇 |
1992年 | 16篇 |
1991年 | 12篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 7篇 |
1987年 | 15篇 |
1986年 | 7篇 |
1985年 | 12篇 |
1984年 | 7篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1973年 | 6篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1968年 | 3篇 |
排序方式: 共有652条查询结果,搜索用时 15 毫秒
591.
592.
593.
Luke A. Gibbons Carl Rafferty Kerry Robinson Marta Abad Francis Maslanka Nikky Le Jingjie Mo Kevin Clark Fiona Madden Ronan Hayes Barry McCarthy Christopher Rode Jim O'Mahony Rosemary Rea Caitlin O'Mahony Hartnett 《Biotechnology progress》2022,38(2):e3223
The Quality by Design (QbD) approach to the production of therapeutic monoclonal antibodies (mAbs) emphasizes an understanding of the production process ensuring product quality is maintained throughout. Current methods for measuring critical quality attributes (CQAs) such as glycation and glycosylation are time and resource intensive, often, only tested offline once per batch process. Process analytical technology (PAT) tools such as Raman spectroscopy combined with chemometric modeling can provide real time measurements process variables and are aligned with the QbD approach. This study utilizes these tools to build partial least squares (PLS) regression models to provide real time monitoring of glycation and glycosylation profiles. In total, seven cell line specific chemometric PLS models; % mono-glycated, % non-glycated, % G0F-GlcNac, % G0, % G0F, % G1F, and % G2F were considered. PLS models were initially developed using small scale data to verify the capability of Raman to measure these CQAs effectively. Accurate PLS model predictions were observed at small scale (5 L). At manufacturing scale (2000 L) some glycosylation models showed higher error, indicating that scale may be a key consideration in glycosylation profile PLS model development. Model robustness was then considered by supplementing models with a single batch of manufacturing scale data. This data addition had a significant impact on the predictive capability of each model, with an improvement of 77.5% in the case of the G2F. The finalized models show the capability of Raman as a PAT tool to deliver real time monitoring of glycation and glycosylation profiles at manufacturing scale. 相似文献
594.
Kathryn E. Arnold Alistair B. A. Boxall A. Ross Brown Richard J. Cuthbert Sally Gaw Thomas H. Hutchinson Susan Jobling Judith C. Madden Chris D. Metcalfe Vinny Naidoo Richard F. Shore Judit E. Smits Mark A. Taggart Helen M. Thompson 《Biology letters》2013,9(4)
The use of human and veterinary pharmaceuticals is increasing. Over the past decade, there has been a proliferation of research into potential environmental impacts of pharmaceuticals in the environment. A Royal Society-supported seminar brought together experts from diverse scientific fields to discuss the risks posed by pharmaceuticals to wildlife. Recent analytical advances have revealed that pharmaceuticals are entering habitats via water, sewage, manure and animal carcases, and dispersing through food chains. Pharmaceuticals are designed to alter physiology at low doses and so can be particularly potent contaminants. The near extinction of Asian vultures following exposure to diclofenac is the key example where exposure to a pharmaceutical caused a population-level impact on non-target wildlife. However, more subtle changes to behaviour and physiology are rarely studied and poorly understood. Grand challenges for the future include developing more realistic exposure assessments for wildlife, assessing the impacts of mixtures of pharmaceuticals in combination with other environmental stressors and estimating the risks from pharmaceutical manufacturing and usage in developing countries. We concluded that an integration of diverse approaches is required to predict ‘unexpected’ risks; specifically, ecologically relevant, often long-term and non-lethal, consequences of pharmaceuticals in the environment for wildlife and ecosystems. 相似文献
595.
596.
598.
Sarah E. Lower Owais Gilani Madden J. Tuffy Deeshani N. Patel Zhengkai Zhu Moria C. Chambers 《Ecological Entomology》2023,48(1):90-101
- The degree to which host, pathogen, and environmental characteristics determine fitness outcomes in response to infection across the tree of life is a key question in ecoimmunology. Because infection experiments require large sample sizes and careful controls, studies have generally been limited to lab-adapted organisms.
- Photinus pyralis is a charismatic firefly that is abundant during its annual summer emergence in the Eastern United States. Here, we assess the importance of host condition, pathogen identity and dose, and pre-infection environment on survival outcomes in response to bacterial infection in wild-caught adult male P. pyralis.
- Although survival after sterile saline injection was not statistically different from survival of uninjected controls, survival kinetics support sterile saline injection as the most appropriate control.
- Serratia marcescens and Providencia rettgeri infections increased mortality, especially at high doses. In contrast to fruit fly studies, Providencia sneebia, Pseudomonas aeruginosa, and Enterococcus faecalis infections did not. Infection with higher doses of P. rettgeri had an increased risk of death for fireflies caught later in the season than those captured earlier, but seasonality did not significantly interact with dose to impact mortality with any of the other bacterial species.
- These results highlight the importance of considering host, pathogen, and environmental factors when investigating infection outcomes in wild-caught, non-model systems. The differences in survival between fireflies and fruit flies emphasise that further studies in a broad array of organisms are needed to explore the diversity of infection responses across the tree of life.
599.
The activity of purified DNA photolyase from Baker's yeast is enhanced by a compound (Activator (III)) obtained from yeast by chloroform extraction ion exchange chromatography and gel filtration. Thin layer chromatography and spectral data indicate that the compound is homogeneous. Activator III emits at 350 and 440 nm when excited at 290 nm, and emits at 440 nm when excited at 358 nm. After acid hydrolysis, emission at 440 nm is produced only by excitation at 358 nm, indicating that activator (III) contains two separate chromophoric moieties. The chromophore excited by 358 nm light has a pK of 9-11, while the other chromophore has a pK of 4-5, and possibly of 9-11. The enhancement of photolytic activity by activator (III) at a concentration equimolar with that of the enzyme and the similarity of the fluorescent spectra of the activator with that of heat-denatured photolyase, suggests that the activator may be the chromophore associated with the enzyme. 相似文献
600.